Literature DB >> 11254688

Biological activity of soluble CD100. II. Soluble CD100, similarly to H-SemaIII, inhibits immune cell migration.

S Delaire1, C Billard, R Tordjman, A Chédotal, A Elhabazi, A Bensussan, L Boumsell.   

Abstract

CD100 is a human 150-kDa homodimer expressed at the surface of most hemopoietic cells, and its gene belongs to the Ig and semaphorin gene families. Semaphorin genes encode soluble and membrane-bound proteins, most of which have been shown to act as chemorepellents on growth cone guidance. CD100 is discrete, as it is a transmembrane leukocyte surface molecule that can also exist in a soluble form. While our previous studies using mAbs suggested that the transmembrane form of CD100 plays a role in lymphocyte activation, no function was shown for its soluble form. Here, we investigated the effect of soluble CD100 in a cell migration assay; both CD100 spontaneously shed from a stable transfectant and soluble recombinant CD100 inhibited spontaneous and chemokine-induced migration of human monocytes. Interestingly, only the dimeric form of CD100 exerted an effect. Moreover, soluble CD100 inhibited migration of cells from monocytic and B cell lineages. A similar inhibitory effect on migration was observed with H-SemaIII, but not H-SemaIV, semaphorins. In addition, both CD100 and H-SemaIII were recognized by two CD100 mAbs in an ELISA, and one of these mAb abolished the inhibitory effect of each of these semaphorins. We also provide evidence that CD100 and H-SemaIII act through the same receptor on immune cells, which is not neuropilin-1. Furthermore, we describe a function on immune cells for H-SemaIII, a semaphorin to date only studied in the nervous system.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11254688     DOI: 10.4049/jimmunol.166.7.4348

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  57 in total

Review 1.  Neuronal migration and molecular conservation with leukocyte chemotaxis.

Authors:  Yi Rao; Kit Wong; Michael Ward; Claudia Jurgensen; Jane Y Wu
Journal:  Genes Dev       Date:  2002-12-01       Impact factor: 11.361

Review 2.  To move or not to move? Semaphorin signalling in cell migration.

Authors:  Luca Tamagnone; Paolo M Comoglio
Journal:  EMBO Rep       Date:  2004-04       Impact factor: 8.807

Review 3.  Regulation of immune cell responses by semaphorins and their receptors.

Authors:  Hyota Takamatsu; Tatsusada Okuno; Atsushi Kumanogoh
Journal:  Cell Mol Immunol       Date:  2010-02-01       Impact factor: 11.530

Review 4.  Semaphorins: a new class of immunoregulatory molecules.

Authors:  Noriko Takegahara; Atsushi Kumanogoh; Hitoshi Kikutani
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-09-29       Impact factor: 6.237

5.  Antitumor Effects of Anti-Semaphorin 4D Antibody Unravel a Novel Proinvasive Mechanism of Vascular-Targeting Agents.

Authors:  Iratxe Zuazo-Gaztelu; Marta Pàez-Ribes; Patricia Carrasco; Laura Martín; Adriana Soler; Mar Martínez-Lozano; Roser Pons; Judith Llena; Luis Palomero; Mariona Graupera; Oriol Casanovas
Journal:  Cancer Res       Date:  2019-06-25       Impact factor: 12.701

Review 6.  Minding the gaps to promote thrombus growth and stability.

Authors:  Lawrence F Brass; Li Zhu; Timothy J Stalker
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

Review 7.  Plexin structures are coming: opportunities for multilevel investigations of semaphorin guidance receptors, their cell signaling mechanisms, and functions.

Authors:  Prasanta K Hota; Matthias Buck
Journal:  Cell Mol Life Sci       Date:  2012-06-29       Impact factor: 9.261

8.  Suppression of bone formation by osteoclastic expression of semaphorin 4D.

Authors:  Takako Negishi-Koga; Masahiro Shinohara; Noriko Komatsu; Haruhiko Bito; Tatsuhiko Kodama; Roland H Friedel; Hiroshi Takayanagi
Journal:  Nat Med       Date:  2011-10-23       Impact factor: 53.440

9.  PKC induces release of a functional ectodomain of the guidance cue semaphorin6A.

Authors:  Riley M St Clair; Caroline M Dumas; Kori S Williams; Matthew T Goldstein; Elizabeth A Stant; Alicia M Ebert; Bryan A Ballif
Journal:  FEBS Lett       Date:  2019-08-16       Impact factor: 4.124

10.  Candidate gene analysis of semaphorins in patients with Alzheimer's disease.

Authors:  Chiara Villa; Eliana Venturelli; Chiara Fenoglio; Milena De Riz; Diego Scalabrini; Francesca Cortini; Maria Serpente; Claudia Cantoni; Nereo Bresolin; Elio Scarpini; Daniela Galimberti
Journal:  Neurol Sci       Date:  2009-12-03       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.